THEME: "Frontiers in Biotechnology and Bioengineering Research"
23-24 Sep 2024
Village Hotel Changi, Singapore
Precigenetics, United States
Title: Leveraging Machine Learning and Vibrational Spectroscopy for Enhanced Cancer Diagnostics
Parmita Mishra is the founder and CEO of Precigenetics, leading the development of advanced
non-invasive diagnostic tools that integrate biophotonics with machine learning. Whilst completing
studies at the University of Pennsylvania in computational biology and bioinformatics, Parmita is
dedicated to pushing the boundaries of healthcare technology, with a particular focus on
non-invasive diagnostics.